Search - tctmd.com

Displaying 81 - 100 of 476

Sort: Relevancy | Date

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

Caitlin E. Cox

January 26, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

Presenter: Lucas Lauder

October 25, 2023

Advertisement

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Venous Stents: How to Choose Among the Wealth of Options

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

January 2024 Dispatch for the CV Team

The Biggest News of 2023: TCTMD’s Top 10

Top Endovascular News of 2023

AHA Selects 2023’s Leading Cardiovascular Research

New Carotid Stent Systems Associated With Low Stroke Risk

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content